The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Latysheva T.V.

National Research Center “Institute of Immunology”, Federal Biomedical Agency, Moscow, Russia

Latysheva E.A.

National Research Center “Institute of Immunology”, Federal Biomedical Agency, Moscow, Russia

Martynova I.A.

National Research Center “Institute of Immunology”, Federal Biomedical Agency, Moscow, Russia

A place of intravenous immunoglobulins in current clinical practice: Privigen is a novel 10% immunoglobulin

Authors:

Latysheva T.V., Latysheva E.A., Martynova I.A.

More about the authors

Journal: Therapeutic Archive. 2016;88(4): 82‑87

Views: 3581

Downloaded: 878


To cite this article:

Latysheva TV, Latysheva EA, Martynova IA. A place of intravenous immunoglobulins in current clinical practice: Privigen is a novel 10% immunoglobulin. Therapeutic Archive. 2016;88(4):82‑87. (In Russ.)
https://doi.org/10.17116/terarkh201688482-87

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.